237 related articles for article (PubMed ID: 34692824)
1. Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing
Agegnehu A; Worku M; Nigussie D; Lulu B; Tadesse BT
Biomed Res Int; 2020; 2020():6679029. PubMed ID: 34692824
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
[TBL] [Abstract][Full Text] [Related]
3. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
4. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
Akram M; Shahid M; Khan AU
Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
[TBL] [Abstract][Full Text] [Related]
5. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae.
Al Yousef SA; Younis S; Farrag E; Moussa HSh; Bayoumi FS; Ali AM
Ann Clin Lab Sci; 2016 Jul; 46(4):393-400. PubMed ID: 27466299
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.
Flokas ME; Detsis M; Alevizakos M; Mylonakis E
J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789
[TBL] [Abstract][Full Text] [Related]
8. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
[TBL] [Abstract][Full Text] [Related]
10. The Magnitude of Carbapenemase and ESBL Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia.
Seman A; Sebre S; Awoke T; Yeshitela B; Asseffa A; Asrat D; Abebe T; Mihret A
Adv Exp Med Biol; 2022; 1369():117-128. PubMed ID: 34914083
[TBL] [Abstract][Full Text] [Related]
11. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
[TBL] [Abstract][Full Text] [Related]
12. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization and epidemiology of extended-spectrum
Djim-Adjim-Ngana K; Mbiakop BW; Oumar LA; Munshili Njifon HL; Tchinda Fossi C; Enyegue ELE; Mouiche Mouliom MM; Fodouop Chegaing SP; Deweerdt L; Yanou NN; Nguinkal JA
Front Public Health; 2023; 11():1187934. PubMed ID: 37457273
[TBL] [Abstract][Full Text] [Related]
14. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
15. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Abera B; Kibret M; Mulu W
PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
[TBL] [Abstract][Full Text] [Related]
16. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
[TBL] [Abstract][Full Text] [Related]
17. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
He XT; Chang CN; Yu CH; Wang CC
Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of extended spectrum beta lactamase in urinary isolates.
Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
[TBL] [Abstract][Full Text] [Related]
19. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
Gales AC; Sader HS; Jones RN;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):289-99. PubMed ID: 12493177
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
